15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Erasca Inc, 7 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $18.00 to $30.00, a moderate spread. The average target of $22.56 sits 38% above the current $16.30. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 0% this year and 0% next, consensus EPS building from about $-0.13 next quarter toward $-0.62 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Moderate Buy
Strong Buy00%
Buy778%
Hold222%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Erasca Inc.
As of Sep, 7 of 9 firms rate ERAS a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ERAS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.13
Range $-0.17 – $-0.07 · 8 analysts · +32% YoY
Next period, 8 analysts expect Erasca Inc to earn $-0.13 a share (range $-0.17 – $-0.07), versus $-0.10 a year earlier. Full-year consensus is $-0.98, growing to $-0.62 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 8 analysts · +0% YoY
Revenue is expected to reach $0 (range $0 – $0), +0.0% year-over-year. Full-year consensus is $0, rising to $0 next year.
Top analysts covering Erasca Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ERAS.
#1
Michael Schmidt
Guggenheim · Rank #2
Buy
$21.00+28.8% to target
Overall win rate
55%
+ Follow
#2
JH
Jeffrey Hung
Morgan Stanley · Rank #3
Hold
$2.00-87.7% to target
Overall win rate
64%
+ Follow
#3
Anupam Rama
JP Morgan · Rank #75
Buy
$23.00+41.1% to target
Overall win rate
51%
+ Follow
#4
Andres Y. Maldonado
HC Wainwright & Co. · Rank #227
Buy
$22.00+35.0% to target
Overall win rate
39%
+ Follow
#5
Alec Stranahan
B of A Securities
Hold
$20.00+22.7% to target
Coverage
—
+ Follow
ERAS stock forecast FAQ
What is ERAS's average 12-month price target?+
The 9 analysts with a live target average $22.56 for Erasca Inc over the next 12 months, ranging from a $30.00 high to a $18.00 low.
Is ERAS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 9 analyst ratings, 7 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ERAS?+
The Street-high target is $30.00 (Stifel), and the Street-low is $18.00 (Piper Sandler). The average of all 9 active targets is $22.56.
How many Wall Street analysts cover ERAS?+
9 analysts have an active rating on Erasca Inc, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering ERAS?+
Among analysts who currently cover ERAS, Michael Schmidt of Guggenheim has the strongest overall Quantellect track record (Rank #2). Their current call is Buy with a $21.00 target.
What is Erasca Inc's projected EPS for next quarter?+
The consensus estimate is $-0.13 per share (range $-0.17 – $-0.07) across 8 analysts. Full-year EPS is projected at $-0.98, rising to $-0.62 the following year.
How much revenue is Erasca Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading ERAS lately?+
As of Sep, 7 of 9 firms rate ERAS a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ERAS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
